EUVIMEDOntdek EUVIMED
Open access

Evaluation of Chinese HIV Mobile Apps by Researchers and Patients With HIV: Quality Evaluation Study

Peng Liu iD, Lingmeng Wang iD, Fuzhi Wang iD

JMIR mHealth and uHealth · 2024-01-26 · 12 · e52573

DOI: 10.2196/52573 ↗

At a glance

Journal article in JMIR mHealth and uHealth, published online on 2024-01-26. Written by Peng Liu and 2 co-authors. Institution: School of Health Management, Bengbu Medical College, Bengbu, China. Major MEDLINE topics: Mobile Applications, Acquired Immunodeficiency Syndrome. Cited 6 times so far (Crossref); 44 references. The full text is freely available in PubMed Central.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Background

Against the backdrop of globalization, China remains one of the most heavily burdened countries in Asia with regard to AIDS. However, many high-risk groups and patients affected by AIDS may be less likely to actively seek care from medical institutions because of fear of experiencing shame or discrimination. Mobile apps provide a promising avenue for supporting the prevention, diagnosis, and treatment of AIDS. However, a comprehensive systematic evaluation of these mobile apps’ functionality and quality has not been conducted yet.

Objective

This study aims to identify the available mobile apps for AIDS in China, assess and discuss the functional features and quality of these Chinese AIDS mobile apps, and offer decision support for patients and clinical practitioners in accessing high-quality AIDS mobile apps. Furthermore, based on the evaluation results, recommendations for improvement will be provided.

Methods

A systematic search was conducted on the Qimai app data platform, the Aladdin WeChat applet data platform, and WeChat to identify mobile apps related to AIDS. A snowball sampling method was used to supplement the potentially overlooked apps. The selected mobile apps underwent a rigorous screening process based on unified criteria. Subsequently, assessments were independently undertaken by 3 separate researchers and 2 patients with HIV, using both the Mobile App Rating Scale (MARS) and the User Mobile App Rating Scale (uMARS). Quantitative interpretations of the data were facilitated by the MedCalc statistical software (version 20.217, MedCalc Software).

Results

A total of 2901 AIDS mobile apps were included in the study, with 2897 identified through information retrieval and an additional 4 added via snowball sampling. After a rigorous selection process, 21 apps were determined to be usable. Among them, the Hong Feng Wan app achieved the highest combined average score, calculated based on the MARS (3.96, SD 0.33) and uMARS (4.47, SD 0.26). Overall, there was no significant correlation between MARS and uMARS (rapp quality total score=0.41; P=.07; rsubjective quality=0.39; P=.08). A notable issue was the widespread lack of user privacy protection, with only 24% (5/21) of the apps offering this feature.

Conclusions

The number of available Chinese AIDS mobile apps is limited, with WeChat applets dominating the market. Nonetheless, the performance of WeChat mini-apps is generally inferior to that of independent apps, and there may be significant discrepancies between assessments conducted by researchers and those provided by genuine end users, emphasizing the necessity of involving real users in the development and evaluation of HIV mobile apps. In addition, developers of these Chinese HIV mobile apps need to devote attention to improving privacy protection mechanisms, in addition to considering the evaluations of researchers and real users. This will help attract more users and increase user loyalty.

Subjects

MeSH terms (MEDLINE)

Mobile ApplicationsAcquired Immunodeficiency SyndromeHumansChina

Author keywords

HIVevaluationmobile appmobile phone

Authors and institutions

  • School of Health Management, Bengbu Medical College, Bengbu, China.
  • Innovation Team of Health Information Management and Application Research, Bengbu Medical College, Bengbu, China.

ORCID profiles: Peng Liu, Lingmeng Wang, Fuzhi Wang

Cite

APA

Liu, P., Wang, L., & Wang, F. (2024). Evaluation of Chinese HIV Mobile Apps by Researchers and Patients With HIV: Quality Evaluation Study. JMIR mHealth and uHealth, 12, e52573. https://doi.org/10.2196/52573

Vancouver

Liu P, Wang L, Wang F. Evaluation of Chinese HIV Mobile Apps by Researchers and Patients With HIV: Quality Evaluation Study. JMIR mHealth and uHealth. 2024;12:e52573. doi:10.2196/52573

BibTeX
@article{Liu2024,
  author = {Liu, Peng and Wang, Lingmeng and Wang, Fuzhi},
  title = {Evaluation of Chinese HIV Mobile Apps by Researchers and Patients With HIV: Quality Evaluation Study},
  journal = {JMIR mHealth and uHealth},
  year = {2024},
  volume = {12},
  pages = {e52573},
  doi = {10.2196/52573}
}
Start for free →